Kenya Requests Zaire Ebola Vaccine from WHO Over Possible Cross-Protection

NAIROBI, Kenya - In response to the ongoing Bundibugyo virus outbreak, the Ministry of Health has sought 10,000 doses of the Zaire Ebola virus vaccine from the World Health Organization (WHO), according to a report on Oct 24. The objective is to immunize 5,000 healthcare workers and other frontline responders. Health Director-General Patrick Amoth indicated that the administration believes the vaccine might provide cross-protection against the Bundibugyo strain, owing to resemblances between the two viruses.

Speaking to Capital FM News, Amoth elaborated that the targeted vaccination aims to safeguard individuals at increased risk of infection. The Kenyan government is intensifying its measures to curb the outbreak. It's important to note that while the Zaire Ebola vaccine is intended to shield against the Zaire species of the Ebola virus, its efficacy against the Bundibugyo species remains unverified.

Therefore, the anticipated cross-protection remains a matter awaiting scientific confirmation. This request is part of broader endeavors to bolster the safeguarding of frontline personnel engaged in surveillance, patient care, and outbreak response efforts.